Nursing Interventions for Blood Transfusion Reactions

Blood transfusions save lives every day in hospitals worldwide. But despite careful screening and matching, transfusion reactions can still occur, requiring nurses to act swiftly and decisively. Understanding these reactions and knowing exactly how to respond can make the difference between a minor complication and a life-threatening emergency.

Understanding blood transfusion reactions 🔗

Blood transfusion reactions occur when the body responds adversely to donated blood or blood components. These reactions can be classified as acute or delayed, depending on when symptoms appear. Acute reactions typically occur during the transfusion or within 24 hours, while delayed reactions can develop days to weeks after the transfusion.

The most frequent manifestations include fever, urticaria, chills, and itching. While some symptoms resolve with minimal intervention, others signal serious complications requiring immediate action. Nurses must monitor patients closely during the first 15 minutes of transfusion, as life-threatening reactions typically manifest during this critical window.

Types of acute transfusion reactions 🔗

Febrile non-hemolytic transfusion reaction 🔗

Febrile non-hemolytic transfusion reaction is the most common type of transfusion reaction. Patients develop fever during or within four hours after transfusion, with temperatures rising at least 1°C above baseline. The reaction occurs when recipient antibodies react with donor leukocytes or when cytokines released during blood storage trigger an inflammatory response.

Management involves stopping the transfusion immediately and administering antipyretics as ordered. Using leukocyte-poor blood products significantly reduces the frequency and severity of these reactions in patients requiring multiple transfusions.

Acute hemolytic transfusion reaction 🔗

This represents one of the most serious transfusion complications. Acute hemolytic reactions most commonly result from ABO incompatibility, usually due to clerical errors in patient identification or blood labeling. The reaction is estimated to occur in 1 in 38,000 to 1 in 70,000 transfusions.

Symptoms appear rapidly and include low back pain, chills, tachycardia, flushing, tachypnea, hypotension, and a sense of impending doom. The patient may also develop hemoglobinuria, causing red or dark brown urine. When incompatible blood enters circulation, recipient antibodies attack donor red blood cells, causing massive hemolysis that can lead to acute renal failure and cardiovascular collapse.

Allergic reactions 🔗

Allergic reactions occur when the immune system reacts to proteins in donor plasma. Mild reactions present with flushing, hives, rash, and itching. However, severe reactions can progress to laryngeal edema and difficulty breathing, potentially leading to anaphylaxis.

Treatment depends on severity. For mild reactions, the transfusion may be paused while antihistamines are administered. Severe reactions require immediate discontinuation of the transfusion, administration of epinephrine, corticosteroids, and airway management.

Immediate nursing interventions for transfusion reactions 🔗

Stop the transfusion 🔗

The moment a transfusion reaction is suspected, the transfusion must be stopped immediately. This is the single most important intervention. Do not discard the blood bag or tubing, as these will be needed for laboratory investigation.

Maintain IV access 🔗

Keep the IV line open with 0.9% normal saline to maintain venous access for medications and to support renal perfusion. This is particularly crucial in hemolytic reactions where maintaining adequate urine output helps prevent acute kidney injury.

Notify the healthcare team 🔗

Immediately inform the physician and the blood bank about the suspected reaction. The blood bank will perform additional testing and clerical checks to identify the cause and prevent future incidents.

Monitor vital signs closely 🔗

Check and document vital signs at 15-minute intervals or more frequently based on patient condition. Watch for signs of deterioration including hypotension, tachycardia, fever spikes, and respiratory distress.

Collect specimens 🔗

Draw post-transfusion blood samples from the opposite arm used for transfusion. Send both the blood samples and the donor blood unit with tubing to the laboratory for analysis. Testing typically includes direct antiglobulin test, blood type reconfirmation, and crossmatch verification.

Specific management strategies 🔗

For hemolytic reactions 🔗

Beyond stopping the transfusion and maintaining IV access, management focuses on preventing renal failure through aggressive fluid administration and maintaining urine output. Monitor for signs of disseminated intravascular coagulation, a serious complication where widespread clotting leads to bleeding. Diuretics may be ordered to promote kidney function.

For febrile reactions 🔗

After ruling out more serious reactions, administer antipyretics like acetaminophen as ordered. A cooling blanket may be used if fever exceeds 40°C. For patients with recurrent febrile reactions, leukocyte-poor red blood cells should be used for future transfusions.

For allergic reactions 🔗

Mild allergic reactions are treated with antihistamines like diphenhydramine and corticosteroids. The transfusion may be resumed slowly once symptoms resolve, following facility protocol. Severe reactions require epinephrine, oxygen therapy, and close airway monitoring. Patients with severe reactions should receive washed blood products in future transfusions to remove plasma proteins.

Prevention through evidence-based practice 🔗

Prevention remains the most effective strategy. Nurses serve as the final safety checkpoint before blood administration, making meticulous verification procedures essential. Always perform a two-nurse verification of patient identity, blood type, and unit numbers at the bedside before starting any transfusion.

Most acute hemolytic reactions result from clerical errors in patient identification or mislabeled specimens. Never skip verification steps, even under time pressure. Start transfusions slowly and remain with the patient during the critical first 15 minutes.

For patients requiring frequent transfusions, consider preventive measures. Leukocyte-reduced blood components reduce the frequency of febrile reactions, minimize alloimmunization risk, and decrease cytomegalovirus transmission. Some facilities use prestorage leukoreduction, which removes white blood cells before storage, preventing cytokine accumulation.

Documentation and follow-up 🔗

Complete documentation is crucial when a transfusion reaction occurs. Record the time symptoms appeared, vital signs, interventions performed, and patient response. Document the volume of blood transfused before stopping and note all specimens sent for testing. This information guides future transfusion decisions and helps identify patterns.

Before discharge, educate patients about delayed reactions. Symptoms can appear up to 30 days post-transfusion and include unexplained fever, jaundice, or decreasing hemoglobin levels. Instruct patients to seek immediate medical attention if these symptoms develop.

What do you think? How confident do you feel in recognizing the early signs of different transfusion reactions? What strategies could improve safety verification processes in your clinical setting?

References

1. https://www.ncbi.nlm.nih.gov/books/NBK482202/
2. https://nurseslabs.com/blood-transfusion/
3. https://www.ncbi.nlm.nih.gov/books/NBK594497/
4. https://healthandwillness.org/blood-transfusion-reactions/
5. https://en.wikipedia.org/wiki/Febrile_non-hemolytic_transfusion_reaction
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC9843350/
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC2847337/
8. https://www.ncbi.nlm.nih.gov/books/NBK448158/
9. https://en.wikipedia.org/wiki/Acute_hemolytic_transfusion_reaction
10. https://openstax.org/books/clinical-nursing-skills/pages/13-4-blood-transfusions
11. https://www.nursetogether.com/blood-transfusion-nursing-diagnosis-care-plan/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC11753523/
13. https://www.sciencedirect.com/science/article/abs/pii/S0268960X20300692